Correlation Between Inozyme Pharma and Amylyx Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Inozyme Pharma and Amylyx Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inozyme Pharma and Amylyx Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inozyme Pharma and Amylyx Pharmaceuticals, you can compare the effects of market volatilities on Inozyme Pharma and Amylyx Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inozyme Pharma with a short position of Amylyx Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inozyme Pharma and Amylyx Pharmaceuticals.
Diversification Opportunities for Inozyme Pharma and Amylyx Pharmaceuticals
0.71 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Inozyme and Amylyx is 0.71. Overlapping area represents the amount of risk that can be diversified away by holding Inozyme Pharma and Amylyx Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Amylyx Pharmaceuticals and Inozyme Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inozyme Pharma are associated (or correlated) with Amylyx Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Amylyx Pharmaceuticals has no effect on the direction of Inozyme Pharma i.e., Inozyme Pharma and Amylyx Pharmaceuticals go up and down completely randomly.
Pair Corralation between Inozyme Pharma and Amylyx Pharmaceuticals
Given the investment horizon of 90 days Inozyme Pharma is expected to under-perform the Amylyx Pharmaceuticals. In addition to that, Inozyme Pharma is 2.09 times more volatile than Amylyx Pharmaceuticals. It trades about -0.34 of its total potential returns per unit of risk. Amylyx Pharmaceuticals is currently generating about -0.11 per unit of volatility. If you would invest 391.00 in Amylyx Pharmaceuticals on November 2, 2024 and sell it today you would lose (40.00) from holding Amylyx Pharmaceuticals or give up 10.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inozyme Pharma vs. Amylyx Pharmaceuticals
Performance |
| Timeline |
| Inozyme Pharma |
| Amylyx Pharmaceuticals |
Inozyme Pharma and Amylyx Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inozyme Pharma and Amylyx Pharmaceuticals
The main advantage of trading using opposite Inozyme Pharma and Amylyx Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inozyme Pharma position performs unexpectedly, Amylyx Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Amylyx Pharmaceuticals will offset losses from the drop in Amylyx Pharmaceuticals' long position.| Inozyme Pharma vs. Day One Biopharmaceuticals | Inozyme Pharma vs. X4 Pharmaceuticals | Inozyme Pharma vs. Acumen Pharmaceuticals | Inozyme Pharma vs. Mereo BioPharma Group |
| Amylyx Pharmaceuticals vs. Terns Pharmaceuticals | Amylyx Pharmaceuticals vs. Acumen Pharmaceuticals | Amylyx Pharmaceuticals vs. Inozyme Pharma | Amylyx Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Transaction History View history of all your transactions and understand their impact on performance |